T. +31 649 998 203 | +34 644 368 922 ( IES Medical )

Abram et al. Individualised flow-controlled versus pressure-controlled ventilation in a porcine oleic acid-induced acute respiratory distress syndrome model. Eur J Anaesth 2023

In experimental ARDS individualized FCV improved P/F ratio (+35%; P=0.07), while a lower minute volume (-29%; P=0.005) was required to obtain even lower PaCO2 levels (-20%; P=0.006) as compared to standard of care PCV in experimental (oleic acid induced) ARDS. This improved gas exchange may relate to the reduced pulmonary shunt fraction (-63%; P=0.008) that was observed. Hemodynamic stability was improved in the subjects ventilated by FCV evidenced by less noradrenaline (-70%; P=0.037) needed to maintain the mean arterial pressure >65 mmHg. These data, together with less mechanical power applied with FCV (-40%; P=0.001), underline the lung protective potential of FCV.

Get back to Literature

SEE OUR PRODUCTS

  • Tritube
  • Cricath
  • Evone
  • Ventrain

NEWS

  • Publication ‘Core topic in airway management’
  • European commission supports Ventinova
  • and more….

LITERATURE

Read the latest publications about the applications and use of our products.

CONTACT US

Ventinova Medical
Meerenakkerplein 7
5652 BJ Eindhoven (NL)

T. +31 (0)40 7516020
E. [email protected]